APOE ϵ4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors

AIDS

Volumn 24, Issue 10, 2010, Pages 1471-1479

  Spector, Stephen A ^a   Singh, Kumud K ^a   Gupta, Saurabh ^a   Cystique, Lucette A ^c   Jin, Hua ^a   Letendre, Scott ^b   Schrier, Rachel ^b   Wu, Zunyou ^a   Hong, Kun X ^a   Yu, Xin ^a   Shi, Chuan ^a   Heaton, Robert K ^a  

^a PEKING UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

apolipoprotein E; China; cognitive impairment; HIV; host genetics; mannose binding lectin 2

Indexed keywords

ANTIRETROVIRUS AGENT; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 2; APOLIPOPROTEIN E EPSILON 3; APOLIPOPROTEIN E EPSILON 4; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; DNA; INTERLEUKIN 4; MANNOSE BINDING LECTIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VIRUS RNA; MANNOSE BINDING LECTIN; MBL2 PROTEIN, HUMAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALLELE; ARTICLE; BLOOD DONOR; CD4 LYMPHOCYTE COUNT; CHINA; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; UNIVARIATE ANALYSIS; DISEASE COURSE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; PATHOPHYSIOLOGY; VIROLOGY;

ADULT; APOLIPOPROTEINS E; BLOOD DONORS; CHINA; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MANNOSE-BINDING LECTIN; NEUROPSYCHOLOGICAL TESTS;

EID: 77953898603     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328339e25c     Document Type: Article

References (36)

1. UNAIDS/WHO. 2007 AIDS epidemic update. http://data.unaids.org/pub/ EPISlides/2007/2007-epiupdate-en.pdf; 2009.
2. Yu ES, Xie Q, Zhang K,Lu P, Chan LL. HIV infection and AIDS in China, 1985 through 1994. Am J Public Health 1996; 86:1116-1122.
3. Zheng X, Tian C, Choi KH, Zhang J, Cheng H, Yang X, et al. Injecting drug use and HIV infection in southwest China. AIDS 1994; 8:1141-1147.
4. Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 2007; 27:86-92.
5. Hult B, Chana G, Masliah E, Everall I. Neurobiology of HIV. Int Rev Psychiatry 2008; 20:3-13.
6. McArthur JC. HIV dementia: an evolving disease. J Neuroim-munol 2004; 157:3-10.
7. Nath A, Sacktor N. Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system. Curr Opin Neurol 2006; 19:358-361.
8. Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007; 21:1915-1921.
9. Heaton RK, Cysique LA, Jin H, Shi C, Yu X, Letendre S, et al. Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neu-rovirol 2008; 14:536-549.
10. Cysique L, Letendre SL, Ake C, Jin H, Franklin DR, Gupta S, et al. and the HIV Neurobehavioral Research Center Group. Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS 2010; 24:983-990.
11. Boven LA, van der Bruggen T, van Asbeck BS, Marx JJ, Nottet HS. Potential role of CCR5 polymorphism in the development of AIDS dementia complex. FEMS Immunol Med Microbiol 1999; 26:243-247.
12. Meyer L, Magierowska M, Hubert JB, Rouzioux C, Deveau C, Sanson F, et al. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group. AIDS 1997; 11:F73-F78.
13. R lymphocyte count and HIV-1 RNA load. J Infect Dis 2005; 191:1971-1980.
14. Singh KK, Hughes MD, Chen J, Spector SA. Impact of MCP-1-2518-G allele on the HIV-1 disease of children in the United States. AIDS 2006; 20:475-478.
15. Gonzalez E, Rovin BH, Sen L, CookeG, DhandaR, Mummidi S, et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci USA 2002; 99:13795-13800.
16. Cysique LA, Jin H, Franklin DR Jr, Morgan EE, Shi C, Yu X, et al. Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study. J Int Neuropsychol Soc 2007; 13:781-790.
17. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 2004; 26:307-319.
18. Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, et al. The HNRC 500: neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1995; 1:231-251.
19. Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 2004; 26:759-778.
20. Singh KK, Barroga CF, Hughes MD, Chen J, Raskino C, McKin-ney RE, Spector SA. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection. J Infect Dis 2003; 188:1461-1472.
21. Singh KK, Hughes MD, Chen J, Phiri K, Rousseau C, Kuhn L, et al. Associations of chemokine receptor polymorphisms With HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by antiretrovirals. J Acquir Immune Defic Syndr 2008; 49:259-265.
22. Dobson CB, Sales SD, Hoggard P, Wozniak MA, Crutcher KA. The receptor-binding region of human apolipoprotein E has direct antiinfective activity. J Infect Dis 2006; 193:442-450.
23. Cedazo-Minguez A. Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities. J Cell Mol Med 2007; 11:1227-1238.
24. Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res 2009; 50 (Suppl):S183-S188.
25. Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, Hall C. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 1998; 4:1182-1184.
26. Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes OA, et al. Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. J Neuroimmunol 2004; 157:197-202. (Pubitemid 39576655)
27. Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, et al. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci USA 2008; 105:8718-8723.
28. Urosevic N, Martins RN. Infection and Alzheimer's disease: the APOE epsilon4 connection and lipid metabolism. J Alzheimers Dis 2008; 13:421-435.
29. Martin I, Dubois MC, Saermark T, Ruysschaert JM. Apolipopro-tein A-1 interacts with the N-terminal fusogenic domains of SIV (simian immunodeficiency virus) GP32 and HIV (human immunodeficiency virus) GP41: implications in viral entry. Biochem Biophys Res Commun 1992; 186:95-101.
30. Arora M, Munoz E, Tenner AJ. Identification of a site on mannan-binding lectin critical for enhancement of phagocytosis. J Biol Chem 2001; 276:43087-43094.
31. Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsono-phagocytosis. Immunol Rev 2001; 180:86-99.
32. Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 2001; 38:133-149. (Pubitemid 32786772)
33. Garred P, Voss A, Madsen HO, Junker P. Association of man-nose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2001; 2:442-450.
34. Turner MW, Hamvas RM. Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2000; 2:305-322.
35. Catano G, Agan BK, Kulkarni H, Telles V, Marconi VC, Dolan MJ, Ahuja SK. Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations. J Infect Dis 2008; 198:72-80.
36. Singh KK, Lieser A, Ruan PK, Fenton T, Spector SA. An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1-related disease in children. J Allergy Clin Immunol 2008; 122:173-180; 180 e171-172.